Joint Formulary & PAD

Levodopa with carbidopa and entacapone - Parkinson's disease

You are here : Home > Formulary Search > Levodopa with carbidopa and entacapone - Parkinson's disease

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
 

Status 2

See narrative
Formulations :
  • Intestinal gel
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
NFD2
NHSE
SPC
Restrictions / Comments :
Important

This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an applicationto the APC.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Levodopa with carbidopa and entacapone
Indication :
Parkinson's disease
Group Name :
Keywords :
Brand Names Include :
Stalevo, Stanek, Sastravi, Lecigon
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

06 Mar 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.

Other Indications

Below are listed other indications that Levodopa with carbidopa and entacapone is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Parkinson's disease.